Chinese Academy of Sciences;Shanghai Institutes for Biological Sciences
发明人:
申请号：
EP16795914.7
公开号：
EP3299023A4
申请日:
2016.05.20
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to a hypoxia-treated mesenchymal stem cell and the use thereof. The present invention discloses for the first time that treating mesenchymal stem cells with hypoxia can significantly promote alleviating or therapeutic effects of mesenchymal stem cells on inflammatory diseases. The present invention also discloses that the hypoxia-treated mesenchymal stem cell is capable of producing insulin-like growth factor-2, which plays a central role in the treatment of inflammatory diseases with the hypoxia-treated mesenchymal stem cell.
